117 pages •
By Infiniti Research Limited
• May 2016
REGENERATIVE MEDICINE MARKET IN AMERICAS
This branch of tissue engineering and molecularbiology is promising and is driven by demand from patients, development of cell therapy, tissue scaffold, and gene therapy products, and increase in the number of pipeline products.
Upon acquiring Blue Heron Biotech in August 2010, OriGene gained capabilities to offer complete molecularbiology services, including codon optimization, gene synthesis, protein expression and assay development.